US 10415037
Compositions and methods for silencing hepatitis B virus gene expression
granted A61KA61K31/713A61K47/18
Quick answer
US patent 10415037 (Compositions and methods for silencing hepatitis B virus gene expression) held by ARBUTUS BIOPHARMA CORPORATION expires Mon Sep 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ARBUTUS BIOPHARMA CORPORATION
- Grant date
- Tue Sep 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K31/713, A61K47/18, A61K47/24, A61K47/28